Will Roche Be Among The First To Launch An Approved COVID Self-Test In Germany?
Roche's new CE-marked nasal-swab antigen test could be a good candidate for approval within Germany's recently liberalized COVID-19 self-test market.
You may also be interested in...
In its first quarter 2021 sales earnings report, Roche highlighted the strength of its diagnostics business as biosimilars cannibalize its pharmaceutical revenues.
In Germany, a draft reguation circulated to industry associations proposes the sale of COVID-19 antigen tests directly to the public. If the amendment to Germany's medical devices regulations is approved, the onus will be on manufacturers to submit viable tests for approval, with the country's in-vitro testing industry association suggesting that this could be achieved in a matter of weeks.
Consumer healthcare firms are perfectly placed to lead the charge in fighting climate change while benefitting from the transition to a greener, healthier world. However, taking advantage of the green opportunity means putting environmental, social and governance (ESG) at the center of how OTC companies measure and reward success and treating the health of people and planet as a single, related issue, argues Bayer Consumer Health's sustainability guru Daniella Foster.